ArticleFuture oncology (London, England)2018
Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET.
Scott C Flanders et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.